MAKO Surgical (Nasdaq: MAKO ) recently announced that it was raising $40 million in capital by selling an additional 3 million shares of stock. Is the need for extra capital a sign that the company is in trouble? Or was this something expected that many have seen coming for a long time? In this video, Motley Fool health care analyst Brenton Flynn answers these questions and tells us why MAKO opted to raise equity instead of borrowing against an existing credit line. Most importantly, he discusses what the news means for the company -- and shareholders -- going forward.
The recent market sell-off of MAKO Surgical shares has many wondering whether the potential growth prospects of the robotic surgery company make this stock a buy or a stock to stay away from. To answer this question, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading.